Hetvi Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 20-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.08 Cr
as on 20-12-2024
- Revenue 25.45%
(FY 2022)
- Profit -3.67%
(FY 2022)
- Ebitda -8.17%
(FY 2022)
- Net Worth 21.73%
(FY 2022)
- Total Assets 35.98%
(FY 2022)
About Hetvi Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹10.08 Cr.
Patel Dahyabhai, Patel Mohanbhai, and Sanjaykumar Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ2019PTC106393
- Company No.
106393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hetvi Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Patel Dahyabhai  | Director | 04-Feb-2019 | Current |
| Patel Mohanbhai | Director | 04-Feb-2019 | Current |
| Sanjaykumar Patel | Director | 21-Dec-2020 | Current |
Financial Performance of Hetvi Lifesciences.
Hetvi Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.45% increase. The company also saw a slight decrease in profitability, with a 3.67% decrease in profit. The company's net worth Soared by an impressive increase of 21.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hetvi Lifesciences?
Unlock access to Hetvi Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 25 Sep 2023 | ₹8.00 M | Open |
Sidbi Creation Date: 15 Dec 2022 | ₹4.50 Cr | Open |
Sidbi Creation Date: 24 Dec 2020 | ₹1.78 Cr | Open |
How Many Employees Work at Hetvi Lifesciences?
Hetvi Lifesciences has a workforce of 11 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetvi Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetvi Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
